# LINAGLIPTIN
> **ANDA208423** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2024-09-03
## Drug
- **FDA Application Number:** ANDA208423
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LINAGLIPTIN
- **Generic name:** Linagliptin
- **Active ingredients:** LINAGLIPTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **First approval:** 2024-09-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208423)
---
*AI Analytics · CC0 1.0*